-

Torrid Holdings Inc. (CURV) Shareholder Notice: Robbins LLP Reminds Investors of Upcoming Lead Plaintiff Deadline in Class Action Against Torrid Holdings Inc.

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Torrid Holdings Inc. (NYSE: CURV) common stock in or traceable to the Company's July 2021 initial public offering ("IPO") for remedies pursuant to the Securities Act of 1933. Torrid is a direct-to-consumer brand of women's plus-size apparel and intimates.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Torrid. Shareholders who want to be appointed lead plaintiff for the class must file their papers by January 14, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: Torrid Holdings Inc. (CURV) Issued a Materially False and Misleading Registration Statement in Support of its IPO

According to the complaint, leading up to the IPO, Torrid claimed to be experiencing rapid sales growth and an impressive recovery following a temporary downturn in the face of the initial phases of the COVID-19 pandemic. In its IPO, Torrid sold 12.65 million shares at $21 per share, generating $265 million in proceeds. However, all of the shares sold were by Torrid insiders and none of the proceeds went to the Company.

In connection with the IPO, defendants failed to disclose that in the first half of 2021 Torrid had experienced a temporary surge in demand as a result of changed consumer behaviors in response to the COVID-19 pandemic and government stimulus and that such ephemeral demand trends had dissipated and were not internally projected to continue following the IPO. Further, Torrid was suffering from severe supply chain disruptions caused by the emergence of the Delta variant of COVID-19, which had first emerged in May 2021, and was running materially below historical inventory levels as a result, and therefore, had insufficient inventory to meet expected consumer demand for its fiscal third quarter of 2021. This late inventory arrival materially impaired the Company from effectively matching consumer buying trends, creating an undisclosed risk of increased markdowns and promotional activities necessary to sell undesirable inventory. Finally, defendants failed to disclose that Torrid’s CFO planned to retire shortly after the IPO.

By the end of September 2022, the price of Torrid stock fell to a low of just $4.06 per share, over 80% below the IPO price.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Torrid Holdings Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:CURV

Release Summary
Torrid Holdings Inc. (CURV) Issued a Materially False and Misleading Registration Statement in Support of its IPO
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Nektar Therapeutics Class Action Reminder – Robbins LLP Encourages NKTR Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nektar Therapeutics (NASDAQ: NKTR) securities between February 26, 2025 and December 15, 2025. Nektar is a biopharmaceutical company focused on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders. The Company’s lead product candidate is rezpegaldesleukin, a novel, first-in-class regulat...

Robbins LLP Encourages SMCI Stockholders to Contact the Firm for Information About the Class Action Against Super Micro Computer, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Super Micro Computer, Inc. (NASDAQ: SMCI) securities between April 30, 2024 and March 19, 2026. Super Micro is a technology company that designs, develops, and manufactures high-performance server and storage systems, primarily for artificial intelligence (“AI”), data center, and cloud solutions customers.For more information, submit a form, em...

Robbins LLP Urges COTY Stockholders to Contact the Firm for Information About the Class Action Against Coty Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coty Inc. (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026. Coty together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? November 5,...
Back to Newsroom